BiotechTube
Jubilant HollisterStier

Jubilant HollisterStier

Spokane, United States· Est.
jublhs.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Jubilant HollisterStier is a century-old, established leader in the sterile injectables contract manufacturing space. It offers end-to-end services including fill-finish, lyophilization, inspection, and packaging, catering to a global clientele developing complex biologics, vaccines, and small/large molecule therapeutics. The company is recognized for manufacturing excellence, operational scale, and a strong focus on building regulatory confidence, which is evidenced by high client retention and recent industry awards. As part of Jubilant Pharma, it leverages significant resources and a long-term legacy in pharmaceutical manufacturing.

Drug DeliveryVaccinesBiologics

Technology Platform

Advanced sterile fill-finish and lyophilization manufacturing platform with automated lines, -55°C lyophilizers, CIP/SIP systems, and integrated inspection/packaging capabilities for injectable drugs and biologics.

Funding History

1
UndisclosedUndisclosed

Opportunities

The global surge in biologics, vaccines, and complex injectable therapeutics drives strong demand for high-quality CMO services.
The company's goal to serve 300 million patients annually by 2026 highlights a clear capacity expansion and market capture opportunity.
Its expertise in lyophilization and flexible clinical-scale manufacturing positions it well for the growing pipeline of novel, sensitive drug products.

Risk Factors

Major risks include regulatory compliance failures at its manufacturing site, which could halt production and damage its reputation.
The business faces intense competition from other large CMOs and potential pricing pressure from clients.
Operational risks like batch failures, supply chain disruptions, and dependence on key client programs also pose significant threats.

Competitive Landscape

JHS competes in the global sterile injectables CMO market against large players like Lonza, Catalent, and Baxter, as well as many specialized and regional manufacturers. Its differentiation is based on a century of experience, a 'white-glove' service model, deep lyophilization expertise, and a strong focus on regulatory confidence. Competition is intense on price, technological capability, capacity availability, and quality reputation.

More companies in Biologics / Biosimilars →More companies in United States →